SCHEMBL8305199

SCHEMBL8305199

O=C1NC(=O)C(Cc2ccc(OCCON=Cc3cccnc3)cc2)S1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.51
FFAR1 O14842 7/20 0.51
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
RXRA P19793 2/20 0.48
CYP3A4 P08684 1/20 0.48
PPARA Q07869 2/20 0.47
RARG P13631 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
MPC2 O95563 1/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305197 1.00 PPARG (0.51) PPARGFFAR1LMNAGAAHTT
SCHEMBL8310359 0.88 FFAR1 (0.52) PPARGFFAR1RXRACYP3A4PPARA
SCHEMBL8310364 0.88 FFAR1 (0.52) PPARGFFAR1RXRACYP3A4PPARA
SCHEMBL8305933 0.88 FFAR1 (0.62) PPARGFFAR1RXRAPPARARARG
SCHEMBL8305936 0.88 FFAR1 (0.62) PPARGFFAR1RXRAPPARARARG
SCHEMBL8310741 0.84 PPARG (0.56) PPARGFFAR1RXRACYP3A4PPARA
SCHEMBL8310743 0.84 PPARG (0.56) PPARGFFAR1RXRACYP3A4PPARA
SCHEMBL8308970 0.84 PPARG (0.70) PPARGFFAR1RXRACYP3A4PPARA
SCHEMBL8308973 0.84 PPARG (0.70) PPARGFFAR1RXRACYP3A4PPARA
SCHEMBL8308201 0.83 PPARG (0.59) PPARGFFAR1RXRACYP3A4PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed